Parents' and children's experiences of participating in a randomized controlled clinical trial: AIDIT-QS

Peter Sand1, Emelie Kinberg2, Frida Sundberg3,4

  • 1Department of Psychology, University of Gothenburg, Gothenburg, Sweden.

Insights

Parents and children found participating in a type 1 diabetes clinical trial rewarding, despite some burden. They would recommend research participation to others, highlighting the need for clear study information.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Trial Methodology
  • Patient-Reported Outcomes

Background:

  • Family burden associated with pediatric complex randomized controlled trials (RCTs) is under-researched.
  • Limited studies explore the family's perspective on participating in research for severe childhood illnesses.
  • Type 1 diabetes diagnosis presents unique challenges for families entering clinical research.

Purpose of the Study:

  • To explore parents' and children's experiences participating in a type 1 diabetes clinical trial.
  • To understand motivations, decision-making processes, and overall experiences of research participation.
  • To identify factors influencing family engagement in pediatric clinical research.

Main Methods:

  • Qualitative study involving interviews with 16 parents and 9 children shortly after a type 1 diabetes diagnosis.
  • Independent researcher conducted semi-structured interviews focusing on inducement, decision-making, and experiences.
  • Exploration of parental (mothers and fathers) and child perspectives on trial participation.

Main Results:

  • Parents were motivated by a desire to improve diabetes treatment for all children and their own child.
  • Older children participated more in decision-making; clear communication is crucial post-diagnosis.
  • While the intervention group experienced some burden, participants in both groups recommended future research involvement.

Conclusions:

  • Family participation in pediatric type 1 diabetes trials is viewed positively, despite challenges.
  • Effective communication strategies are essential for informed consent and decision-making in clinical research.
  • Positive experiences and willingness to recommend underscore the value of family engagement in pediatric research.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Cochran's Q Test01:17

Cochran's Q Test

Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...